Remimazolam Has Low Oral Bioavailability and No Potential for Misuse in Drug-Facilitated Sexual Assaults, with or Without Alcohol: Results from Two Randomised Clinical Trials

• Những tác giả chính: Marija Pesic (Tác giả), Thomas Stöhr (Tác giả), Joachim Ossig (Tác giả), Keith Borkett (Tác giả), Martin Donsbach (Tác giả), Van-Anh Dao (Tác giả), Lynn Webster (Tác giả), Frank Schippers (Tác giả)
• Định dạng: Sách
• Được phát hành: Adis, Springer Healthcare, 2020-08-01T00:00:00Z.
• Những chủ đề: article
• Truy cập trực tuyến: Connect to this object online.

Abstract Background and Objectives Remimazolam is a new ultra-short-acting benzodiazepine currently being developed for intravenous use in procedural sedation, general anaesthesia, and intensive care unit sedation. Benzodiazepines represent a drug class associated with drug-facilitated sexual assaul...